Seeger Weiss urges a full-court review of proposed negotiation class in opioid litigation

Seeger Weiss LLP filed a petition for rehearing en banc on October 8, 2020, seeking a reconsideration of a proposed negotiation class for In re National Prescription Opiate Litigation by the Sixth Circuit of the U.S. Court of Appeals. Coauthored with by co-lead class counsel, Jayne Conroy of Simmons Hanley Conroy LLC, as well as […]

October 9, 2020

Seeger Weiss LLP filed a petition for rehearing en banc on October 8, 2020, seeking a reconsideration of a proposed negotiation class for In re National Prescription Opiate Litigation by the Sixth Circuit of the U.S. Court of Appeals.

Coauthored with by co-lead class counsel, Jayne Conroy of Simmons Hanley Conroy LLC, as well as special counsel and class counsel for the proposed class, the petition describes the recent 2-1 decision striking down the proposed class as an “attempt to rewrite the history” of Rule 23 of the Federal rules of Civil Procedure.

“Given the stakes of the underlying public health crisis — and the broader stakes in ensuring proper interpretation of the rules — this is simply too important a case to allow a bare 2-1 panel majority to control the outcome,” the class wrote.

“The plaintiffs are moving forward with the MDL litigation, preparing for trials and exploring and discussing potential resolutions with various defendants,” Conroy and Seeger told Law360 in a recent article on the petition. “Meanwhile, we are seeking en banc review because the negotiation class approved by the MDL court is an important mechanism that deserves the full consideration of the entire court of appeal.”

Related News

March 26, 2026
Jury Finds Meta and YouTube Liable in Landmark California Social Media Addiction Trial

A California jury has found Meta and YouTube negligent in designing platforms that harmed a young user, ordering Meta to pay $4.2 million and YouTube to pay $1.8 million in combined compensatory and punitive damages, in what is being called a landmark verdict in social media addiction litigation. Seeger Weiss Founding Partner Christopher Seeger serves […]

Read More
March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More